Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018
Domingo, C., Ellerbrok, H., Koopmans, M., Nitsche, A., Leitmeyer, K., Charrel, R.N., Reusken, C.B.E.M.
Increased risk for autochthonous vector-borne infections transmitted by aedes albopictus in continental europe
Gossner, C.M., Ducheyne, E., Schaffner, F.
Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, july 2017 to March 2018
Gossner, C.M., Haussig, J.M., de Bellegarde de Saint Lary, C., Kaasik Aaslav, K., Schlagenhauf, P., Sudre, B.
The European medical corps: First public health team mission and future perspectives
Haussig, J.M., Severi, E., Baum, J.H., Vanlerberghe, V., Laiseca, A., Defrance, L., Brailescu, C., Coulombier, D., Jansa, J.
Prevention and control measures for yellow fever
A safe, effective and inexpensive yellow fever attenuated vaccine, known as YF 17D, has been used for more than half a century. The vaccine is highly effective. Travelers to endemic areas are advised to check their vaccination status and get vaccinated if necessary.